Seth Fischer
Director/Board Member at AGILE THERAPEUTICS, INC.
Net worth: 19 196 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John Johnson | M | 66 |
Ortho-McNeil Pharmaceutical LLC
 Ortho-McNeil Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Ortho-McNeil Pharmaceutical LLC manufactures pharmaceutical products. Its products include ditropan, elmiron, modicon, otho cept and ortho novum etc. The company was founded in 1993 and is headquartered in Raritan, NJ.
Healthquest Capital Management Co LLC
 Healthquest Capital Management Co LLC Investment ManagersFinance HealthQuest Capital Management Co LLC (HealthQuest Capital ) is a private equity firm founded in 2013 by Garheng Kong. The firm is headquartered in Redwood City, California. | 21 years |
| Scott Coiante | M | 57 | 11 years | |
| Nicole Vitullo | F | 66 | 19 years | |
| Scott Braunstein | M | 60 | 6 years | |
| Al Altomari | M | 65 | 20 years | |
| Joaquin Duato | M | 61 | 35 years | |
| J. Carroll | M | 74 | 4 years | |
| Robert Wills | M | 70 | 31 years | |
| Sheldon Koenig | M | 58 | 4 years | |
| Geoffrey P. Gilmore | M | 58 | 10 years | |
| Steven Pfanstiel | M | 51 | 3 years | |
| Michael Tomsicek | M | 58 |
Trius Therapeutics, Inc.
 Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA. | 5 years |
| Joseph Oliveto | M | 56 | 7 years | |
| Nora Brennan | F | 55 | 4 years | |
| Lisa Giles | F | 65 | 4 years | |
| William Hait | M | 74 | 17 years | |
| Marianne Andreach | F | - | - | |
| Josephine Torrente | F | 58 | 3 years | |
| Joseph Wolk | M | 57 | 26 years | |
| Christine Silverstein | F | 41 | 1 years | |
| Benjamin Halladay | M | 38 | 4 years | |
| Kimberly Whelan | F | - | 5 years | |
| Sharon Barbari | F | 70 | 4 years | |
| Charles Austin | M | 68 | 4 years | |
| Amy Welsh | F | 53 | 4 years | |
| Avery Williams | F | - |
Healthquest Capital Management Co LLC
Healthquest Capital Management Co LLC Investment ManagersFinance HealthQuest Capital Management Co LLC (HealthQuest Capital ) is a private equity firm founded in 2013 by Garheng Kong. The firm is headquartered in Redwood City, California. | 2 years |
| Benjamin Looker | M | 42 | 2 years | |
| David Kabakoff | M | 76 |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA.
Healthquest Capital Management Co LLC
Healthquest Capital Management Co LLC Investment ManagersFinance HealthQuest Capital Management Co LLC (HealthQuest Capital ) is a private equity firm founded in 2013 by Garheng Kong. The firm is headquartered in Redwood City, California. | 18 years |
| Sara Nochur | M | 63 | 3 years | |
| Sandra A. Carson | M | 70 | 4 years | |
| Elan Ezickson | M | 60 | 5 years | |
| David King | M | 67 |
Healthquest Capital Management Co LLC
Healthquest Capital Management Co LLC Investment ManagersFinance HealthQuest Capital Management Co LLC (HealthQuest Capital ) is a private equity firm founded in 2013 by Garheng Kong. The firm is headquartered in Redwood City, California. | 11 years |
| Alan Fuhrman | M | 67 | 4 years | |
| Anne Mulcahy | F | 70 | 15 years | |
| Antonio M. Gotto | M | 88 | 10 years | |
| Jay Shepard | M | 65 | 6 years | |
| Tim Mayleben | M | 63 | 16 years | |
| Martha Manning | F | 69 | 4 years | |
| Eric Warren | M | 76 | 3 years | |
| Garheng Kong | M | 49 |
Healthquest Capital Management Co LLC
Healthquest Capital Management Co LLC Investment ManagersFinance HealthQuest Capital Management Co LLC (HealthQuest Capital ) is a private equity firm founded in 2013 by Garheng Kong. The firm is headquartered in Redwood City, California. | 12 years |
| Richard Pasternak | M | 75 | 5 years | |
| Tracy M. Woody | F | 54 | 5 years | |
| John Hubbard | M | 67 | 10 years | |
| Debra Liebert | F | 67 | 9 years | |
| Robert Conway | M | 67 | 20 years | |
| Stephen Rocamboli | M | 52 | 2 years | |
| Peter Fasolo | M | 61 | 18 years | |
| Ajay Madan | M | - |
Healthquest Capital Management Co LLC
Healthquest Capital Management Co LLC Investment ManagersFinance HealthQuest Capital Management Co LLC (HealthQuest Capital ) is a private equity firm founded in 2013 by Garheng Kong. The firm is headquartered in Redwood City, California. | 1 years |
| Jennifer Taubert | F | 60 | 19 years | |
| Glenn Brame | M | 67 | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Joseph W. Turgeon | M | 66 | 9 years | |
| Thomas Riga | M | 48 | 10 years | |
| Timothy Morris | M | 61 | 9 years | |
| Russell C. Deyo | M | 74 | 27 years | |
| Thomas King | M | 69 | 3 years | |
| Christopher Michael Cashman | M | 67 | 8 years | |
| Robert Wilson | M | 83 | 41 years | |
| Alex Gorsky | M | 63 | 35 years | |
| Jeffrey O'Donnell | M | 64 | 10 years | |
| Edward Smith | M | 53 | 8 years | |
| John Schmid | M | 61 |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA. | 9 years |
| Kurt Gustafson | M | 56 | 9 years | |
| Jeffrey Stein | M | 69 |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA. | 6 years |
| Mark Oki | M | 55 | - | |
| Michael H. Ullmann | M | 66 | 33 years | |
| Greg Cash | M | 66 | 3 years | |
| Roy Tanaka | M | 75 |
Biosense Webster, Inc.
 Biosense Webster, Inc. Medical SpecialtiesHealth Technology Biosense Webster, Inc. develops technology solutions for diagnosing heart rhythm disorders. It provides deflectable tip catheter for treating arrhythmia disorder. The company was founded by Wilton W. Webster Jr. and Shlomo Ben-Haim in 1998 and is headquartered in South Diamond Bar, CA. | 19 years |
| Ajit Shetty | M | 77 | 13 years | |
| Mark B. Logan | M | 84 | 15 years | |
| Michael Astrue | M | 67 | 1 years | |
| Peter Y. Tam | M | 60 | 20 years | |
| Matthew Stuckley | M | - | 14 years | |
| James T. Lenehan | M | 75 | 28 years | |
| Matthew Riley | M | - | 4 years | |
| Joseph Scodari | M | 71 | 9 years | |
| Evan Norton | M | 49 | 3 years | |
| Tristen Herrstrom | F | - | - | |
| James Tursi | M | 59 | 8 years | |
| Jeffrey Berkowitz | M | 58 | 6 years | |
| Deborah Larsen | F | - | - | |
| Tracy Guo | F | - | - | |
| Enrique Carrazana | M | 62 | 8 years | |
| Svai Sanford | M | 54 | 3 years | |
| Rick Bartram | M | 63 | 9 years | |
| Allan Shaw | M | 59 | 4 years | |
| Andrew Filler | M | 56 | 4 years | |
| Lisa M. Caperelli | F | - | 6 years | |
| Eric Roberts | M | 59 | 4 years | |
| Curtis Selquist | M | 79 | 36 years | |
| Anand Mehra | M | 48 | 9 years | |
| David Satcher | M | 83 | - | |
| Sam Colin | M | 59 | 2 years | |
| Abhijeet Lele | M | 58 | 10 years | |
| Robert J. Darretta | M | 78 | 39 years | |
| William McKee | M | 62 | 6 years | |
| Karen Ho Hong | M | 52 | 10 years | |
| Alexander Denner | M | 54 | 2 years | |
| James Cullen | M | 81 | 20 years | |
| Susan L. Lindquist | M | 74 | - | |
| Sasha Ellis | F | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 96 | 96.00% |
| Canada | 6 | 6.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Seth Fischer
- Personal Network
